9 insiders reported 29 Form 4 transactions for Immuneering Corp (IMRX) over the past 18 months (most recent 2026-06-24). Recent activity: Zeskind Benjamin J. (PRESIDENT AND CEO) Buy 2,400 shares, Hall Brett Matthew (CHIEF SCIENTIFIC OFFICER) Buy 6,035 shares, Neufeld Leah R (CHIEF PEOPLE OFFICER) Buy 3,628 shares, Brakewood Harold Eugene (Chief Business Officer) Buy 5,250 shares, Schall Thomas J. (Director) Buy 21,645 shares. Source: SEC Form 4.
| Date | Insider | Title | Type | Shares | Value |
|---|---|---|---|---|---|
| 2026-06-24 | Zeskind Benjamin J. | PRESIDENT AND CEO | Buy | 2,400 | $10,948 |
| 2026-06-16 | Hall Brett Matthew | CHIEF SCIENTIFIC OFFICER | Buy | 6,035 | $25,045 |
| 2026-03-17 | Neufeld Leah R | CHIEF PEOPLE OFFICER | Buy | 3,628 | $15,564 |
| 2026-01-21 | Brakewood Harold Eugene | Chief Business Officer | Buy | 5,250 | $24,990 |
| 2026-01-20 | Schall Thomas J. | Director | Buy | 21,645 | $101,082 |
| 2026-01-16 | Hall Brett Matthew | CHIEF SCIENTIFIC OFFICER | Buy | 2,298 | $10,502 |
| 2026-01-15 | Neufeld Leah R | CHIEF PEOPLE OFFICER | Buy | 2,626 | $10,898 |
| 2026-01-14 | Feinberg Peter | Director | Buy | 20,000 | $87,000 |
| 2025-10-07 | Feinberg Peter | Director | Buy | 7,500 | $50,025 |
| 2025-10-02 | Bookman Michael | CHIEF LEGAL OFFICER, SECRETARY | Buy | 1,020 | $6,967 |
| 2025-10-02 | Morales Mallory | Chief Accounting Officer | Buy | 300 | $1,917 |
| 2025-10-02 | Neufeld Leah R | CHIEF PEOPLE OFFICER | Buy | 800 | $5,104 |
| 2025-10-01 | Feinberg Peter | Director | Buy | 7,500 | $52,725 |
| 2025-09-30 | Feinberg Peter | Director | Buy | 5,000 | $35,900 |
| 2025-09-17 | Neufeld Leah R | CHIEF PEOPLE OFFICER | Buy | 11,815 | $16,895 |
| 2025-09-17 | Morales Mallory | Chief Accounting Officer | Buy | 14,497 | $20,731 |
| 2025-09-17 | Hall Brett Matthew | CHIEF SCIENTIFIC OFFICER | Buy | 14,880 | $21,278 |
| 2025-07-07 | HAUSMAN DIANA | Director | Buy | 3,000 | $10,860 |
| 2025-07-07 | Neufeld Leah R | CHIEF PEOPLE OFFICER | Buy | 700 | $2,499 |
| 2025-07-07 | HAUSMAN DIANA | Director | Buy | 2,500 | $9,000 |
| 2025-07-03 | Zeskind Benjamin J. | PRESIDENT AND CEO | Buy | 2,985 | $10,089 |
| 2025-07-03 | Zeskind Benjamin J. | PRESIDENT AND CEO | Buy | 7,015 | $24,763 |
| 2025-06-30 | Schall Thomas J. | Director | Buy | 9,500 | $34,770 |
| 2025-06-24 | Hall Brett Matthew | CHIEF SCIENTIFIC OFFICER | Buy | 6,007 | $14,597 |
| 2025-06-24 | Hall Brett Matthew | CHIEF SCIENTIFIC OFFICER | Buy | 7,415 | $20,020 |
Source: SEC Form 4 filings · as of 2026-06-24